Effect of Paracetamol on Kidney Function in Severe Malaria (PROTECtS)
Evaluating the Renoprotective Effect of Paracetamol in Paediatric Severe Malaria: a Randomised Controlled Trial
Sponsor: Kinshasa Medical Oxford Research Unit
This PHASE3 trial investigates Acute Kidney Injury and Malaria,Falciparum and is currently ongoing. Kinshasa Medical Oxford Research Unit leads this study, which shows 12 recorded versions since 2021 — indicating substantial longitudinal coverage. Longitudinal tracking of infectious disease trials helps identify durability of treatment effects.
Status Flow
Change History
12 versions recorded-
Dec 2025 — Present [monthly]
Unknown PHASE3
Status: Recruiting → Unknown
-
Sep 2025 — Dec 2025 [monthly]
Recruiting PHASE3
-
Sep 2024 — Sep 2025 [monthly]
Recruiting PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Recruiting PHASE3
-
Jul 2023 — Jul 2024 [monthly]
Recruiting PHASE3
▶ Show 7 earlier versions
-
Apr 2022 — Jul 2023 [monthly]
Recruiting PHASE3
-
Feb 2022 — Apr 2022 [monthly]
Recruiting PHASE3
Status: Not Yet Recruiting → Recruiting
-
Oct 2021 — Feb 2022 [monthly]
Not Yet Recruiting PHASE3
-
Jun 2021 — Oct 2021 [monthly]
Not Yet Recruiting PHASE3
-
Jan 2021 — Jun 2021 [monthly]
Not Yet Recruiting PHASE3
-
Apr 2020 — Jan 2021 [monthly]
Not Yet Recruiting PHASE3
-
Feb 2020 — Apr 2020 [monthly]
Not Yet Recruiting PHASE3
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Kinshasa Medical Oxford Research Unit
- Mahidol Oxford Tropical Medicine Research Unit
- University of British Columbia
For direct contact, visit the study record on ClinicalTrials.gov .